Blood NFL can discriminate with good accuracy ALS from neurologically healthy controls (NHCs) and, more relevantly, from other neurodegenerative diseases and ALS-mimic conditions (Gille et al., 2019; Verde et al., 2019). This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.